NR4A1 and invasive breast carcinoma: In this study, we identified significant urinary cadmium/invasive breast cancer associations for hormone receptor-positive (ER+, PR+ and ER+/PR+), but not for hormone receptor-negative (ER−, PR− and ER−/PR−) breast cancer subtypes.